GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings44 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CVS HEALTH CORPORATION

8.2M$588.7M14.8%$57.60+22.84%
10 qtrssince 2023-Q4
Unchanged
0

GLOBAL PAYMENTS INC

6.4M$428.1M10.7%$107.57-27.77%
22 qtrssince 2020-Q4
Increased
66

TENET HEALTHCARE CORP

1.5M$287.8M7.2%$55.91+334.44%
30 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

1.1M$220.6M5.5%$194.84+7.13%
13 qtrssince 2023-Q1
Increased
70
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

6.7M$200.6M5.0%$14.80+118.04%
10 qtrssince 2023-Q4
Decreased
0
QQQQQQ
CALL

INVESCO QQQ TRUST SERIES 1 CL USD INC

328,200$189.4M4.8%
New

THE CIGNA GROUP

498,841$133.1M3.3%$253.73+4.53%
30 qtrssince 2018-Q4
Increased
85

ADVANCED MICRO DEVICES

650,792$132.4M3.3%$209.93-3.10%
2 qtrssince 2025-Q4
Increased
82

THERMO FISHER SCIENTIFIC INC

250,525$123.1M3.1%$449.53+13.03%
4 qtrssince 2025-Q2
Increased
63

VIATRIS INC

9.1M$122.8M3.1%$10.93+36.28%
10 qtrssince 2023-Q4
Decreased
0

DXC TECHNOLOGY CO

8.9M$111.8M2.8%$25.04-58.50%
30 qtrssince 2018-Q4
Increased
56

CENTENE CORP

3.2M$105.2M2.6%$36.96-11.43%
3 qtrssince 2025-Q3
Increased
78

UBER TECHNOLOGIES INC

1.5M$104.7M2.6%$75.33+1.36%
20 qtrssince 2021-Q2
Increased
84

ZOOMINFO TECHNOLOGIES INC

15.9M$95.1M2.4%$10.59-61.77%
8 qtrssince 2024-Q2
Decreased
0
IWMIWM
PUT

ISHARES RUSSELL 2000 ETF ETF

375,000$93M2.3%
New

BLOCK INC

1.4M$82.1M2.1%$66.87-5.94%
3 qtrssince 2025-Q3
Increased
74

META PLATFORMS INC-CLASS A

122,662$70.2M1.8%$656.62-0.23%
5 qtrssince 2025-Q1
Increased
76

APPLIED MATERIALS INC

197,209$67.4M1.7%$285.47+19.58%
2 qtrssince 2025-Q4
Increased
66

ONTO INNOVATION INC

299,721$61.5M1.5%$140.69+47.48%
3 qtrssince 2025-Q3
Decreased
0

DICKS SPORTING GOODS INC

298,911$59.3M1.5%$203.64-1.07%
4 qtrssince 2025-Q2
Increased
50
$4B
AUM
44
Positions
Q1 2026
Filing
Rating · 3.5
Quarterly Portfolio Change
-23%Q4'24$4B+3%Q1'25$4.1B-12%Q2'25$3.6B+26%Q3'25$4.5B+9%Q4'25$4.9B-19%Q1'26$4B
Activity profile
$ moved · Q1'26
New18%Increased17%Decreased37%Exited28%
Composition
Equity vs derivatives
Equity93%Puts2%Calls5%
Holding period
Avg 2.8 years
<1Q14%1-4Q36%1-2Y2%2Y+48%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4B across 44 positions as of Q1 2026. Top holdings: CVS (14.8%), GPN (10.7%), THC (7.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q1 2026 Summary

Active quarter - 6 new positions, 19 exits, 17 increased. Top move: CI (INCREASED, conviction 85). Portfolio: $4.0B across 44 positions.

Top holdings by portfolio weight

Total AUM$4B
CVS14.78%
GPN10.75%
THC7.22%
AMZN5.54%
TEVA5.04%
CI3.34%
AMD3.32%
TMO3.09%
VTRS3.08%
DXC2.81%
Other2.64%

Portfolio allocation by GICS sector

Sectors9
Healthcare48.81%
Technology19.99%
Industrials12.83%
Consumer Cyclical10.60%
Communication Services3.81%
Basic Materials1.51%
Consumer Defensive1.23%
Unknown0.72%
Energy0.50%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used